Genetic analysis systems maker Cepheid said Monday that it received its second clearance from the Food and Drug Administration for a test that identifies a life-threatening bacteria affecting newborns.
Monday, December 11, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment